BC1 cell line therapy(Briacell Therapeutics)

N/A

Report date: 2025/05/14 15:50:21

Base Information

Drug NameBC1 cell line therapy(Briacell Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBriacell Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesBriacell Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A